Biotin-AGE-BSA
$350.00
Syd Labs Biotin-AGE-BSA BP000042-MPR10, The AGE modified BSA was produced by reacting BSA with glucose under sterile conditions for 2 months followed by dialysis and purification. Extent of AGE modification: 25-30 adducts per Biotin-AGE-BSA. Extent of biotinylation: 6-7 biotins per AGE-BSA.
- Details & Specifications
- References
- More Offers
| Catalog No. | BP000042-MPR10 |
|---|---|
| Product Name | Biotin-AGE-BSA |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | Advanced Glycation End Products |
| Source | The AGE modified BSA was produced by reacting BSA with glucose under sterile conditions for 2 months followed by dialysis and purification according to the method described in Valentia et al. (2004). The AGE-BSA was biotinylated and then subjected to dialysis. |
| Formulation | Phosphate-buffered saline (PBS), 1 ug/ml. |
| Endotoxin | < 0.1 EU/ug AGE-BSA as determined by the LAL method. |
| Note | Conditions of optimal Biotin-AGE-BSA performance should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149Fax: 1-617-606-5019Email: message@sydlabs.comOr leave a message with a formal purchaseorder (PO) Or credit card. |
Description
BP000042-MPR10: Biotin-AGE-BSA
Background
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for AGE (RAGE). The fluorescence of Biotin-AGE-BSA was determined by fluorescence spectrometry with Ex./Em.=360/465 nm. The Biotin-AGE-BSA shows a 100-fold increase in fluorescence when compared to the control BSA. Browning of Biotin-AGE-BSA was determined by measuring the absorbance at 320 nm. The Bioin-AGE-BSA shows a 40 fold increase in absorbance when compared to the control BSA.
BP000042-MPR10: Biotin-AGE-BSA
Source: The AGE modified BSA was produced by reacting BSA with glucose under sterile conditions for 2 months followed by dialysis and purification according to the method described in Valentia et al. (2004). The AGE-BSA was biotinylated and then subjected to dialysis.
Formulation: Phosphate-buffered saline (PBS), 1 ug/ml.
Endotoxin: < 0.1 EU/ug AGE-BSA as determined by the LAL method. Preservative: None. QC tests: SDS-PAGE, MALDI-TOF, Fluorescence spectrometry, Absorbance at 320 nm and RAGE binding ELISA. Activity: KD 50-20 nM, as measured by its binding to the immobilized RAGE in an ELISA binding assay. Extent of AGE modification: 25-30 adducts per Biotin-AGE-BSA, as judged by free amine content analysis and MALDI-TOF analysis. Extent of biotinylation: 6-7 biotins per AGE-BSA, as judged by HABA assay and MALDI-TOF analysis. Sterility: 0.2 um membrane-filtered and packaged aseptically. Storage and stability:
Upon receiving, store the product at 2-8°C for up to 1 month. For extended storage, aliquot the solution and freeze at -70°C or -20°C. Avoid repeated freezing and thawing.
Reference: Valencia et al. (2004) Anal. Biochem. 324:68-78
Please remember our product information: Biotin-AGE-BSA: BP000042-MPR10 Syd Labs